People Suffer Tragedy In Social Networks Hard.
If you squander much while on Facebook untagging yourself in unflattering photos and embarrassing posts, you're not alone. A inexperienced study, however, finds that some people take those awkward online moments harder than others. In an online inspection of 165 Facebook users, researchers found that nearly all of them could describe a Facebook common sense in the past six months that made them feel awkward, embarrassed or uncomfortable. But some nation had stronger emotional reactions to the experience, the survey found Dec 2013.
Not surprisingly, Facebook users who put a lot of cattle in socially appropriate behavior or self-image were more likely to be mortified by certain posts their friends made, such as a photo where they're undoubtedly drunk or one where they're perfectly sober but looking less than attractive. "If you're someone who's more modest offline, it makes sense that you would be online too," said Dr Megan Moreno, of Seattle Children's Hospital and the University of Washington.
Moreno, who was not interested in the research, studies brood people's use of social media. "There was a time when folk thought of the Internet as a place you go to be someone else. "But now it's become a place that's an augmentation of your real life". And social sites like Facebook and Twitter have made it trickier for commoners to keep the traditional boundaries between different areas of their lives.
In offline life settle generally have different "masks" that they show to different people - one for your close friends, another for your mom and yet another for your coworkers. On Facebook - where your mom, your best backer and your boss are all among your 700 "friends" - "those masks are blown apart. Indeed, family who use social-networking sites have handed over some of their self-presentation put down to other people, said study co-author Jeremy Birnholtz, director of the Social Media Lab at Northwestern University.
But the extent to which that bothers you seems to depend on who you are and who your Facebook friends are. For the study, Birnholtz's set used flyers and online ads to recruit 165 Facebook users - mainly sophomoric adults - for an online survey. Of those respondents, 150 said they'd had an discomfiting or awkward Facebook experience in the past six months.
Friday 30 October 2015
Wednesday 28 October 2015
Diseases Of The Skin Depend On The Color
Diseases Of The Skin Depend On The Color.
Black women in the United States are much more credible to have considerable blood pressure than black men or ghostly women and men, according to a new study in Dec 2013. The researchers also found that blacks are twice as qualified as whites to have undiagnosed and untreated high blood pressure. "For many years, the zero in for high blood pressure was on middle-aged men who smoked.
Now we know better," said contemplate author Dr Uchechukwu Sampson, an assistant professor of medicine at Vanderbilt University Medical Center in Nashville, Tenn. For the study, which was published in the minutes Circulation: Cardiovascular Quality and Outcomes, researchers examined figures from 70000 people in 12 southeastern states known as the "stroke belt". This zone has higher rates of stroke than anywhere else in the United States.
Black women in the United States are much more credible to have considerable blood pressure than black men or ghostly women and men, according to a new study in Dec 2013. The researchers also found that blacks are twice as qualified as whites to have undiagnosed and untreated high blood pressure. "For many years, the zero in for high blood pressure was on middle-aged men who smoked.
Now we know better," said contemplate author Dr Uchechukwu Sampson, an assistant professor of medicine at Vanderbilt University Medical Center in Nashville, Tenn. For the study, which was published in the minutes Circulation: Cardiovascular Quality and Outcomes, researchers examined figures from 70000 people in 12 southeastern states known as the "stroke belt". This zone has higher rates of stroke than anywhere else in the United States.
A Simple Test Of Memory Can Detect Disease At An Early Stage Of Alzheimer's
A Simple Test Of Memory Can Detect Disease At An Early Stage Of Alzheimer's.
A researcher has developed a condensed remembrance evaluate to help doctors determine whether someone is suffering from the early memory and reasoning problems that often important Alzheimer's disease. In a study in the journal Alzheimer Disease and Associated Disorders, neurologist Dr Douglas Scharre of Ohio State University Medical Center reports that the study detected 80 percent of population with mild thinking and memory problems. It only turned up a treacherous positive - wrongly suggesting that a person has a problem - in five percent of occupy with normal thinking.
In a press release, Scharre said the test could staff people get earlier care for conditions like Alzheimer's disease. "It's a recurring problem. People don't come in antique enough for a diagnosis, or families generally resist making the appointment because they don't want confirmation of their worst fears. Whatever the reason, it's tragic because the drugs we're using now duty better the earlier they are started".
The test can be taken by hand, which Scharre said may help people who aren't untroubled with technology like computers. He's making the tests, which take 15 minutes to complete, elbow free to health workers at www.sagetest.osu.edu. SAGE is a brief self-administered cognitive screening thingumajig to identify Mild Cognitive Impairment (MCI) and early dementia. Average space to complete the test is 15 minutes. The total possible points are 22.
So "They can drive the test in the waiting room while waiting for the doctor. Abnormal test results can round with as an early warning to the patient's family. The results can be a signal that caregivers may requisite to begin closer monitoring of the patient to ensure their safety and good health is not compromised and that they are protected from monetary predators".
In the study, 254 people aged 59 and older took the test. Of those, 63 underwent an in-depth clinical rating to determine their level of cognitive ability. Alzheimer's and the brain. Just fellow the rest of our bodies, our brains change as we age.
A researcher has developed a condensed remembrance evaluate to help doctors determine whether someone is suffering from the early memory and reasoning problems that often important Alzheimer's disease. In a study in the journal Alzheimer Disease and Associated Disorders, neurologist Dr Douglas Scharre of Ohio State University Medical Center reports that the study detected 80 percent of population with mild thinking and memory problems. It only turned up a treacherous positive - wrongly suggesting that a person has a problem - in five percent of occupy with normal thinking.
In a press release, Scharre said the test could staff people get earlier care for conditions like Alzheimer's disease. "It's a recurring problem. People don't come in antique enough for a diagnosis, or families generally resist making the appointment because they don't want confirmation of their worst fears. Whatever the reason, it's tragic because the drugs we're using now duty better the earlier they are started".
The test can be taken by hand, which Scharre said may help people who aren't untroubled with technology like computers. He's making the tests, which take 15 minutes to complete, elbow free to health workers at www.sagetest.osu.edu. SAGE is a brief self-administered cognitive screening thingumajig to identify Mild Cognitive Impairment (MCI) and early dementia. Average space to complete the test is 15 minutes. The total possible points are 22.
So "They can drive the test in the waiting room while waiting for the doctor. Abnormal test results can round with as an early warning to the patient's family. The results can be a signal that caregivers may requisite to begin closer monitoring of the patient to ensure their safety and good health is not compromised and that they are protected from monetary predators".
In the study, 254 people aged 59 and older took the test. Of those, 63 underwent an in-depth clinical rating to determine their level of cognitive ability. Alzheimer's and the brain. Just fellow the rest of our bodies, our brains change as we age.
Tuesday 27 October 2015
The First Drug Appeared During 140-130 BC
The First Drug Appeared During 140-130 BC.
Archeologists investigating an old shipwreck off the seaboard of Tuscany report they have stumbled upon a rare find: a tightly closed tin container with well-preserved c physic dating back to about 140-130 BC. A multi-disciplinary gang analyzed fragments of the green-gray tablets to decipher their chemical, mineralogical and botanical composition. The results proposition a peek into the complexity and sophistication of ancient therapeutics.
So "The research highlights the continuity from then until now in the use of some substances for the remedying of human diseases," said archeologist and lead researcher Gianna Giachi, a chemist at the Archeological Heritage of Tuscany, in Florence, Italy. "The inquire into also shows the carefulness that was taken in choosing complex mixtures of products - olive oil, pine resin, starch - in demand to get the desired therapeutic effect and to help in the preparation and relevance of medicine".
The medicines and other materials were found together in a tight space and are thought to have been originally packed in a box that seems to have belonged to a physician, said Alain Touwaide, scientific director of the Institute for the Preservation of Medical Traditions, in Washington, DC Touwaide is a fellow of the multi-disciplinary team that analyzed the materials. The tablets contained an iron oxide, as well as starch, beeswax, pine resin and a composite of plant-and-animal-derived lipids, or fats.
Touwaide said botanists on the inquiry team discovered that the tablets also contained carrot, radish, parsley, celery, strange onion and cabbage - simple plants that would be found in a garden. Giachi said that the mixture and shape of the tablets suggest they may have been used to treat the eyes, dialect mayhap as an eyewash. But Touwaide, who compared findings from the analysis to what has been understood from ancient texts about medicine, said the metallic component found in the tablets was undoubtedly used not just for eyewashes but also to treat wounds.
The ascertaining is evidence of the effectiveness of some natural medicines that have been used for literally thousands of years. "This bumf potentially represents essentially several centuries of clinical trials. If natural medicine is utilized for centuries and centuries, it's not because it doesn't work".
Archeologists investigating an old shipwreck off the seaboard of Tuscany report they have stumbled upon a rare find: a tightly closed tin container with well-preserved c physic dating back to about 140-130 BC. A multi-disciplinary gang analyzed fragments of the green-gray tablets to decipher their chemical, mineralogical and botanical composition. The results proposition a peek into the complexity and sophistication of ancient therapeutics.
So "The research highlights the continuity from then until now in the use of some substances for the remedying of human diseases," said archeologist and lead researcher Gianna Giachi, a chemist at the Archeological Heritage of Tuscany, in Florence, Italy. "The inquire into also shows the carefulness that was taken in choosing complex mixtures of products - olive oil, pine resin, starch - in demand to get the desired therapeutic effect and to help in the preparation and relevance of medicine".
The medicines and other materials were found together in a tight space and are thought to have been originally packed in a box that seems to have belonged to a physician, said Alain Touwaide, scientific director of the Institute for the Preservation of Medical Traditions, in Washington, DC Touwaide is a fellow of the multi-disciplinary team that analyzed the materials. The tablets contained an iron oxide, as well as starch, beeswax, pine resin and a composite of plant-and-animal-derived lipids, or fats.
Touwaide said botanists on the inquiry team discovered that the tablets also contained carrot, radish, parsley, celery, strange onion and cabbage - simple plants that would be found in a garden. Giachi said that the mixture and shape of the tablets suggest they may have been used to treat the eyes, dialect mayhap as an eyewash. But Touwaide, who compared findings from the analysis to what has been understood from ancient texts about medicine, said the metallic component found in the tablets was undoubtedly used not just for eyewashes but also to treat wounds.
The ascertaining is evidence of the effectiveness of some natural medicines that have been used for literally thousands of years. "This bumf potentially represents essentially several centuries of clinical trials. If natural medicine is utilized for centuries and centuries, it's not because it doesn't work".
Sunday 25 October 2015
Difficulties When Applying For Insurance
Difficulties When Applying For Insurance.
The wobbly rollout of the Affordable Care Act has done some mutilate to the public's opinion of the new health care law, a Harris Interactive/HealthDay opinion poll finds. The percentage of people who support a repeal of "Obamacare" has risen, and now stands at 36 percent of all adults. That's up from 27 percent in 2011. The federal healthiness assurance exchange website, HealthCare dot gov, was launched in October, but detailed problems made it close to impossible for many uninsured Americans to initially choose and enroll in a unheard of health plan.
After a series of fixes were made to the website in November, things have been running more smoothly, although the news enrollment numbers are still far below government projections. The increase in support for repeal of the ordinance appears to come from people who up to now haven't cared one way or the other about it, said Devon Herrick, a companion at the National Center for Policy Analysis, a libertarian think tank. "There's less indecision.
Those who in reality didn't know or didn't care or were indifferent or were uninformed are forming an opinion, and it isn't good". The tally also found that people aren't taking advantage of the law's benefits, either because the rollout has prevented them from signing up or they aren't sensible of what's available to them. Fewer than half of the people who shopped for bond through a marketplace were able to successfully buy coverage, the survey indicated.
Only 5 percent of the uninsured who current in states that are expanding Medicaid said they have signed up for the program. Two-thirds either believe they still aren't single for Medicaid or don't know enough about the program. "These new findings make depressing reading for the authority and supporters of the Affordable Care Act ," said Humphrey Taylor, Harris Poll chairman. Enrollment in both the expanding Medicaid program and in retired insurance available through the exchanges is still unfortunately slow.
However, there is a bright spot for the law's supporters - more than two-thirds of the people who have bought coverage through a robustness insurance marketplace think they got an excellent or pretty good deal. That's the calculate that indicates why the Affordable Care Act eventually will succeed, said Ron Pollack, number one director of Families USA, a health care advocacy group. "It is not queer for a new program to have a hill to climb in terms of its acceptance".
And "As more and more people get enrolled, they will have their friends and they will tell their family members. As that happens, we will see more people decide that the Affordable Care Act is very valuable to them". About 48 percent of Americans brace the Affordable Care Act, saying it either should be red as it stands or have some parts changed.
The wobbly rollout of the Affordable Care Act has done some mutilate to the public's opinion of the new health care law, a Harris Interactive/HealthDay opinion poll finds. The percentage of people who support a repeal of "Obamacare" has risen, and now stands at 36 percent of all adults. That's up from 27 percent in 2011. The federal healthiness assurance exchange website, HealthCare dot gov, was launched in October, but detailed problems made it close to impossible for many uninsured Americans to initially choose and enroll in a unheard of health plan.
After a series of fixes were made to the website in November, things have been running more smoothly, although the news enrollment numbers are still far below government projections. The increase in support for repeal of the ordinance appears to come from people who up to now haven't cared one way or the other about it, said Devon Herrick, a companion at the National Center for Policy Analysis, a libertarian think tank. "There's less indecision.
Those who in reality didn't know or didn't care or were indifferent or were uninformed are forming an opinion, and it isn't good". The tally also found that people aren't taking advantage of the law's benefits, either because the rollout has prevented them from signing up or they aren't sensible of what's available to them. Fewer than half of the people who shopped for bond through a marketplace were able to successfully buy coverage, the survey indicated.
Only 5 percent of the uninsured who current in states that are expanding Medicaid said they have signed up for the program. Two-thirds either believe they still aren't single for Medicaid or don't know enough about the program. "These new findings make depressing reading for the authority and supporters of the Affordable Care Act ," said Humphrey Taylor, Harris Poll chairman. Enrollment in both the expanding Medicaid program and in retired insurance available through the exchanges is still unfortunately slow.
However, there is a bright spot for the law's supporters - more than two-thirds of the people who have bought coverage through a robustness insurance marketplace think they got an excellent or pretty good deal. That's the calculate that indicates why the Affordable Care Act eventually will succeed, said Ron Pollack, number one director of Families USA, a health care advocacy group. "It is not queer for a new program to have a hill to climb in terms of its acceptance".
And "As more and more people get enrolled, they will have their friends and they will tell their family members. As that happens, we will see more people decide that the Affordable Care Act is very valuable to them". About 48 percent of Americans brace the Affordable Care Act, saying it either should be red as it stands or have some parts changed.
Thursday 15 October 2015
Psychologists Give Some Guidance To Adolescents
Psychologists Give Some Guidance To Adolescents.
Teen girls struggling with post-traumatic accent clamour stemming from sexual abuse do well when treated with a type of therapy that asks them to time and confront their traumatic memories, according to a small new study. The study's results suggest that "prolonged airing therapy," which is approved for adults, is more effective at helping adolescent girls affected post-traumatic stress disorder (PTSD) than traditional supportive counseling. "Prolonged exposure is a fount of cognitive behavior therapy in which patients are asked to recount aloud several times their traumatic experience, including details of what happened during the episode and what they thought and felt during the experience," said study founder Edna Foa, a professor of clinical psychology at the University of Pennsylvania.
And "For example, a twist that felt shame and guilt because she did not prevent her father from sexually abusing her comes to realize that she did not have the privilege to prevent her father from abusing her, and it was her father's fault, not hers, that she was abused. During repeated recounting of the traumatizing events, the patient gets closure on those events and is able to put it aside as something horrific that happened to her in the past. She can now continue to develop without being hampered by the traumatic experience".
Foa and her colleagues reported their findings in the Dec 25, 2013 pour of the Journal of the American Medical Association. The researchers focused on a congregation of 61 girls, all between the ages of 13 and 18 and all suffering from PTSD tied up to sexual abuse that had occurred at least three months before the study started. No boys were included in the research.
Roughly half of the girls were given criterion supportive counseling in weekly sessions conducted over a 14-week period. During that time, counselors aimed to cultivate a trusting relation in which the teens were allowed to address their traumatic experience only if and when they felt ready to do so. The other unaggressive group was enlisted in a prolonged exposure therapy program in which patients were encouraged to revisit the commencement of their demons in a more direct manner, albeit in a controlled environment designed to be both contemplative and sensitive.
Teen girls struggling with post-traumatic accent clamour stemming from sexual abuse do well when treated with a type of therapy that asks them to time and confront their traumatic memories, according to a small new study. The study's results suggest that "prolonged airing therapy," which is approved for adults, is more effective at helping adolescent girls affected post-traumatic stress disorder (PTSD) than traditional supportive counseling. "Prolonged exposure is a fount of cognitive behavior therapy in which patients are asked to recount aloud several times their traumatic experience, including details of what happened during the episode and what they thought and felt during the experience," said study founder Edna Foa, a professor of clinical psychology at the University of Pennsylvania.
And "For example, a twist that felt shame and guilt because she did not prevent her father from sexually abusing her comes to realize that she did not have the privilege to prevent her father from abusing her, and it was her father's fault, not hers, that she was abused. During repeated recounting of the traumatizing events, the patient gets closure on those events and is able to put it aside as something horrific that happened to her in the past. She can now continue to develop without being hampered by the traumatic experience".
Foa and her colleagues reported their findings in the Dec 25, 2013 pour of the Journal of the American Medical Association. The researchers focused on a congregation of 61 girls, all between the ages of 13 and 18 and all suffering from PTSD tied up to sexual abuse that had occurred at least three months before the study started. No boys were included in the research.
Roughly half of the girls were given criterion supportive counseling in weekly sessions conducted over a 14-week period. During that time, counselors aimed to cultivate a trusting relation in which the teens were allowed to address their traumatic experience only if and when they felt ready to do so. The other unaggressive group was enlisted in a prolonged exposure therapy program in which patients were encouraged to revisit the commencement of their demons in a more direct manner, albeit in a controlled environment designed to be both contemplative and sensitive.
Tuesday 13 October 2015
The Experimental Drug Against Lung Cancer Prolongs Patients' Lives
The Experimental Drug Against Lung Cancer Prolongs Patients' Lives.
Researchers record they prolonged survival for some patients with advanced non-small room lung cancer, for whom the median survival is currently only about six months. One ruminate on discovered that an experimental sedate called crizotinib shrank tumors in the majority of lung cancer patients with a specific gene variant. An estimated 5 percent of lung cancer patients, or brutally 40000 men and women worldwide, have this gene variant.
A second study found that a double-chemotherapy regimen benefited past it patients, who represent the majority of those with lung cancer worldwide. Roughly 100000 patients with lung cancer in the United States are over the time of 70. "This is our toughest cancer in many ways," said Dr Mark Kris, arbitrator of a Saturday press conference at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. "It affects 220000 Americans each year, and over a million population worldwide. Sadly, it is our nation's - and our world's - foremost cancer".
The initial study, a phase 1 trial, found that 87 percent of 82 patients with advanced non-small chamber lung cancer with a specific mutation of the ALK gene, which makes that gene merge with another, responded robustly to treatment with crizotinib, which is made by Pfizer Inc. "The patients were treated for an unexceptional of six months, and more than 90 percent saw their tumors contract in size and 72 percent of participants remained progression-free six months after treatment," said lessons author Dr Yung-Jue Bang, a professor in the department of internal medicine at Seoul National University College of Medicine in South Korea. Ordinarily, only about 10 percent of patients would be expected to return to treatment.
About half of patients competent nausea, vomiting and diarrhea but these camp effects eased over time. The fusion gene was first discovered to play a duty in this type of lung cancer in 2007. Researchers are now working on a phase 3 trial of the drug. The Korean researchers reported economic ties to Pfizer.
Researchers record they prolonged survival for some patients with advanced non-small room lung cancer, for whom the median survival is currently only about six months. One ruminate on discovered that an experimental sedate called crizotinib shrank tumors in the majority of lung cancer patients with a specific gene variant. An estimated 5 percent of lung cancer patients, or brutally 40000 men and women worldwide, have this gene variant.
A second study found that a double-chemotherapy regimen benefited past it patients, who represent the majority of those with lung cancer worldwide. Roughly 100000 patients with lung cancer in the United States are over the time of 70. "This is our toughest cancer in many ways," said Dr Mark Kris, arbitrator of a Saturday press conference at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. "It affects 220000 Americans each year, and over a million population worldwide. Sadly, it is our nation's - and our world's - foremost cancer".
The initial study, a phase 1 trial, found that 87 percent of 82 patients with advanced non-small chamber lung cancer with a specific mutation of the ALK gene, which makes that gene merge with another, responded robustly to treatment with crizotinib, which is made by Pfizer Inc. "The patients were treated for an unexceptional of six months, and more than 90 percent saw their tumors contract in size and 72 percent of participants remained progression-free six months after treatment," said lessons author Dr Yung-Jue Bang, a professor in the department of internal medicine at Seoul National University College of Medicine in South Korea. Ordinarily, only about 10 percent of patients would be expected to return to treatment.
About half of patients competent nausea, vomiting and diarrhea but these camp effects eased over time. The fusion gene was first discovered to play a duty in this type of lung cancer in 2007. Researchers are now working on a phase 3 trial of the drug. The Korean researchers reported economic ties to Pfizer.
Thursday 8 October 2015
Over The Last Decade Treatment Of Lupus Kidney Disorder Has Improved
Over The Last Decade Treatment Of Lupus Kidney Disorder Has Improved.
Over the whilom 10 years, therapy options for patients with an frantic kidney disorder known as lupus nephritis have vastly improved, according to a new review. This means that patients with lupus nephritis, which is a complexity that can occur in individuals with the autoimmune disease systemic lupus erythematosus (SLE), can now envision a better quality of life, without many of the harsh treatment side effects. The rethinking further indicates that new treatments for this serious kidney disorder are already coming down the pike, and will all things considered lead to even better options in the future.
And "Treatment of lupus nephritis is rapidly changing, becoming safer and more effective," Dr Gerald Appel, of Columbia University College of Physicians and Surgeons in New York City, said in an American Society of Nephrology release release. Appel and Columbia buddy Dr Andrew Bomback pass out their findings in the Nov 1, 2010 online copy of the Journal of the American Society of Nephrology. The authors noted that SLE affects about 1,4 million Americans, mostly women between the ages of 20 and 40.
Over the whilom 10 years, therapy options for patients with an frantic kidney disorder known as lupus nephritis have vastly improved, according to a new review. This means that patients with lupus nephritis, which is a complexity that can occur in individuals with the autoimmune disease systemic lupus erythematosus (SLE), can now envision a better quality of life, without many of the harsh treatment side effects. The rethinking further indicates that new treatments for this serious kidney disorder are already coming down the pike, and will all things considered lead to even better options in the future.
And "Treatment of lupus nephritis is rapidly changing, becoming safer and more effective," Dr Gerald Appel, of Columbia University College of Physicians and Surgeons in New York City, said in an American Society of Nephrology release release. Appel and Columbia buddy Dr Andrew Bomback pass out their findings in the Nov 1, 2010 online copy of the Journal of the American Society of Nephrology. The authors noted that SLE affects about 1,4 million Americans, mostly women between the ages of 20 and 40.
Subscribe to:
Posts (Atom)